copyright 1 MG-SEMAGLUTIDE for Dummies
The trial obtained both its Major endpoints, with semaglutide two.4 mg demonstrating statistically important and exceptional enhancements in liver fibrosis without worsening of steatohepatitis, and resolution of steatohepatitis without worsening of liver fibrosis in individuals with MASH compared to placebo.oneHold all appointments along with your